| Bioactivity | Rolinsatamab is a potent dual IL-4 and IL-13 inhibitor as a fully humanized bispecific monoclonal antibody. Rolinsatamab chimeric antigen receptor sequence T cell. Rolinsatamab can be used in research of immune disease[1]. |
| Name | Rolinsatamab |
| CAS | 2095467-30-2 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ray EL, et, al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245. |